Insider trade

Retension Pharmaceuticals (RTSN)Director bought ~$120K

Franklin M Berger, Director at Retension Pharmaceuticals, bought ~$120K of Retension Pharmaceuticals shares.

~$120K
Approx. value · 10K sh @ $12.00: 10K
Holds after · shares reported

Traded: Oct 13, 2026
Filed: Oct 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 9, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
Oct 13, 2026 · this disclosureInsiderDirector purchased ~$120K of RTSN shares in the open market

What came next

Oct 13, 2026InsiderCEO purchased ~$250K of RTSN shares in the open market
Oct 14, 20265% stakeEric Keller filed an activist stake (13D) of 7.1%
Oct 15, 20265% stakeLaurence W. Lytton reported a passive stake (13G) of 7.4%
Oct 16, 20265% stakePVG ASSET MANAGEMENT CORP reported a passive stake (13G) of 8.3%
Oct 16, 20265% stakeThe B Group, Inc. reported a passive stake (13G) of 10.0%

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Retension Pharmaceuticals

For Retension Pharmaceuticals, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RTSN page.

Other recent filings by Franklin M Berger, Director

The full history of Franklin M Berger, Director is on the profile page.

How this filing works

Explore the data

Other disclosures at Retension Pharmaceuticals

Everything OQRO holds on this company is on its RTSN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data